2,3-dinor-thromboxane b2 has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassi, A; Calapai, G; Caputi, AP; Gregg, E; Lowe, F; Mannucci, C; McEwan, M; Morandi, S; Nunziata, A; Puntoni, R; Russo, GA | 1 |
| Basili, S; Camastra, C; Ciabattoni, G; Cordova, C; Davì, G; Ferro, D; Giammarresi, C; Iuliano, L; Landolfi, R; Rocca, B; Santarone, S; Violi, F | 1 |
2 other study(ies) available for 2,3-dinor-thromboxane b2 and Disease Exacerbation
| Article | Year |
|---|---|
Cardiovascular biomarkers in groups of established smokers after a decade of smoking.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Hemoglobins; Humans; Leukocyte Count; Male; Risk Factors; Sex Factors; Smoking; Tars; Thromboxane B2; Thromboxanes; Young Adult | 2009 |
Increased thromboxane metabolites excretion in liver cirrhosis.
Topics: Adult; Aged; Blood Platelets; Creatinine; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Oxidation-Reduction; Partial Thromboplastin Time; Peptide Fragments; Prothrombin; Radioimmunoassay; Thromboxane A2; Thromboxane B2 | 1998 |